NCT06697197 2026-02-03A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid TumorsBristol-Myers SquibbPhase 1/2 Recruiting413 enrolled
NCT02253992 2020-10-05An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's LymphomaBristol-Myers SquibbPhase 1/2 Terminated232 enrolled 17 charts